Alan C. Dahl brings over 20 years of senior executive, financial, and private equity investing experience to the firm. Mr. Dahl has extensive experience in acquisitions, mergers, and minority investments, and he has helped many management teams successfully chart the path through the inflection points experienced by growing companies in a changing environment. His expertise includes leading numerous transactions, managing turnaround opportunities, growing existing platforms, working with successful management teams, and attracting key executives. Prior to founding EDG, Dahl partnered with Steve Eaton and other investors in transactions that developed into Genoa Healthcare and Housecall. He was a founding member and served on the Board of Genoa, and he was a Board Member and Interim CEO of Housecall, where he led the transition of the company from a subsidiary of a large non-profit to becoming a leading for-profit provider of home care services. From 1991 to 2002, he served on the Board of Directors and played a variety of roles, including Chief Financial Officer and Executive Vice President for Business Development, at Centennial. During this time Centennial grew from a few million in revenue to over $400 million in revenue, completed numerous acquisitions, undertook a successful IPO, and was sold to a large private equity firm in a “going private” transaction. Before his work at Centennial, Dahl was involved in finance, real estate, and healthcare investing. He currently serves on the Boards of Gemino Healthcare Finance, LLC, HealthPro Rehabilitation, Inc., NDC Holdings, Inc., and National HME, Inc. In addition to the boards of Genoa, Housecall, and Centennial, he previously served on the boards of First Call, Regency, and CareSite. He also serves as a board member for two non-profit organizations. Dahl, who is a Certified Public Accountant (inactive), received a Bachelor of Science and a Master of Science in Accounting from Oklahoma State University.